Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 3 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 5 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
MEDESTIME from Charleroi, company number BE0445829321, closed financial year 2025 with a result of € -157,844 after tax. For that financial year MEDESTIME recorded a gross margin of € -38,922 and equity of € -678,663. Compared with financial year 2024, the result moved from € -222,800 to € -157,844. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.
€ -678,663
▼ € 157,844 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -157,844
▲ 29 % less loss than in 2024
Profit after tax over the fiscal year.
€ 1,451
▲ € 1,392 vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -802,610.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 103,070
▼ 16% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 276
▼ 71% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 46,915
Loans from banks and other lenders, long and short.
€ 58,615
▲ 89% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 34,884
▼ 21% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 170,201 | € -22,637 | € -89,823 | € -38,922 | ▲ € 50,901 |
| Profit after taxes | € 83,329 | € -136,180 | € -222,800 | € -157,844 | ▲ € 64,955 |
| Equity | € 11,056 | € -298,018 | € -520,818 | € -678,663 | ▼ € 157,844 |
| Total debts | € 237,991 | € 514,623 | € 777,182 | € 910,409 | ▲ 17% |
| Cash | € 11,145 | € 4,023 | € 59 | € 1,451 | ▲ € 1,392 |
| Land & buildings | € 22,893 | € 15,257 | € 11,440 | € 7,622 | ▼ 33% |
| Retained profit | € -112,890 | € -421,965 | € -644,765 | € -802,610 | ▼ € 157,844 |
| Bank debt | € 60,220 | € 50,600 | € 46,915 | € 46,915 | |
| Balance sheet total | € 249,048 | € 216,605 | € 256,364 | € 231,746 | ▼ 10% |
Key figures of MEDESTIME, fiscal years 2021 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to MEDESTIME?
What happened at MEDESTIME in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 157,844. Source: NBB ↗
- New establishment in Charleroi. KBO
- Wang PAN became a director. NBB
- New establishment in Charleroi. KBO
- Start of the company according to the CBE. KBO
In short
From € 83,329 profit in 2021 to € 157,844 loss in 2025.
Paid € 671 in corporate taxes since 2021.
Best year ever: 2021, with € 83,329 profit.
A new publication or filing at MEDESTIME? We notify you, reason included.
Follow MEDESTIMEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Wang PAN
Director
since 2022
Establishments
Establishment units
Physical locations of this company
Rue de Jumet 81
6041 Charleroi
Rue de Gosselies 13
6040 Charleroi
Active since 15 January 2024
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0445.829.321
- VAT number
- BE 0445.829.321
- Registered office
- Rue de Jumet 81, 6041 Charleroi
- Names & denominations
- MEDESTIME
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 3 December 1991
- Peppol
- Active · Active since 18 Jun 2025
- Activities · NACE
Vervaardiging van elektrische apparaten voor de geneeskunde, de tandheelkunde en de veeartsenijkunde
Vervaardiging van medische en tandheelkundige instrumenten en benodigdheden
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels